FDA risk management white paper
Executive Summary
FDA hopes to complete white paper on risk management before Office of Drug Safety Director Peter Honig, MD, leaves the agency at the end of February to join Merck (1"The Pink Sheet" Jan. 21, p. 21). Honig is co-authoring the paper with Office of Pharmacoepidemiology & Statistical Science Director Paul Seligman, MD...